Articaine Injection, Solution
NDC Package 51004-1010-5
Package Information
Articaine (articaine hydrochloride and epinephrine) injection is articaine HCl and Epinephrine is indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures in adults and pediatric patients 4 years of age or older. This formulation utilizes a injection, solution delivery system. Marketed by Novocol Pharmaceutical Of Canada, Inc., this product is identified by NDC 51004-1010 and is authorized under FDA application NDA020971.
Identification & Billing
- RxCUI: 1595035 - articaine HCl 4 % / EPINEPHrine 1:100,000 in 1.7 mL Dental Cartridge
- RxCUI: 1595035 - 1.7 ML articaine hydrochloride 40 MG/ML / epinephrine 0.01 MG/ML Cartridge
- RxCUI: 1595035 - articaine HCl 4 % / epinephrine 1:100,000 (as epinephrine bitartrate 0.018 MG/ML) 1.7ML Dental Cartridge
- RxCUI: 1595035 - articaine HCl 4 % / epinephrine 1:100,000 1.7 ML Dental Cartridge
Clinical Specifications
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Adrenergic beta-Agonists - [MoA] (Mechanism of Action)
- Amide Local Anesthetic - [EPC] (Established Pharmacologic Class)
- Amides - [CS]
- Catecholamine - [EPC] (Established Pharmacologic Class)
- Catecholamines - [CS]
- Local Anesthesia - [PE] (Physiologic Effect)
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
- beta-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 51004 - Novocol Pharmaceutical Of Canada, Inc.
- 51004-1010 - Articaine
- 51004-1010-5 - 50 CARTRIDGE in 1 CARTON / 1.7 mL in 1 CARTRIDGE
- 51004-1010 - Articaine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51004-1010-5 identifies a specific commercial package of 50 cartridge in 1 carton / 1.7 ml in 1 cartridge of Articaine, a human prescription drug labeled by Novocol Pharmaceutical Of Canada, Inc.. This injection, solution is formulated for submucosal use and contains articaine hydrochloride; epinephrine bitartrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Novocol Pharmaceutical Of Canada, Inc. on June 22, 2015. The current certification is valid through December 31, 2027.
How is this Novocol Pharmaceutical Of Canada, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51004101005. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.